Trial intelligence / Profile preview

Opioid-free anesthesia versus remifentanil-based anesthesia for laparoscopic cholecystectomy

ChiCTR1900022993Phase 4Completed

Sponsor
Hefei First People's Hospital
Start
Jun 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine, lidocaine, esketamine and remifentanil in gallbladder disease (2 arms), sponsored by Hefei First People's Hospital. Primary endpoints: Requirement for rescue analgesics and Postoperative pain score. Started Jun 2021; status: completed.

02

Drugs

dexmedetomidinelidocaineesketamineremifentanil
03

Conditions

gallbladder disease

Beyond the preview

Go deeper on ChiCTR1900022993.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022993.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call